Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Opt Express ; 29(17): 27362-27372, 2021 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-34615154

RESUMO

We report the first demonstration of broadband adiabatic directional couplers in thin-film lithium niobate on insulator (LNOI) waveguides. A three LN-waveguide configuration with each waveguide having a ridge cross section of less than 1 square micron, built atop a layer of SiO2 based on a 500-µm-thick Si substrate, has been designed and constructed to optically emulate a three-state stimulated Raman adiabatic passage system, with which a unique counterintuitive adiabatic light transfer phenomenon in a high coupling efficiency of >97% (corresponding to a >15 dB splitting ratio) spanning telecom S, C, and L bands for both TE and TM polarization modes has been observed for a 2-mm long coupler length. An even broader operating bandwidth of >800 nm of the device can be found from the simulation fitting of the experimental data. The footprint of the realized LNOI adiabatic coupler has been reduced by >99% compared to its bulk counterparts. Such an ultra-compact, broadband LNOI adiabatic coupler can be further used to implement or integrate with various photonic elements, a potential building block for realizing large-scale integrated photonic (quantum) circuits in LN.

2.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 52(6): 917-922, 2021 Nov.
Artigo em Zh | MEDLINE | ID: mdl-34841754

RESUMO

Research and development of artificial biliary substitutes is an indispensable part of modern biliary surgery, bearing great clinical significance on the recovery of the normal functions of the biliary system. The implantation of artificial biliary substitutes may cause the blockage or stenosis of the biliary duct at the transplantation site, which is the most urgent problem in the research of artificial biliary substitutes. The fundamental cause of the problem is tissue hyperplasia caused by chronic inflammatory stimulation of artificial biliary substitutes. The regeneration of new bile duct tissue at the transplantation site can provide a solution to this problem. By looking at the literature from China and abroad, this paper reviewed the research and development of non-degradable artificial bile duct, degradable artificial bile duct and tissue-engineered artificial bile duct in order to provide reference for the further development of biliary replacements. Future studies should focus on the rapid formation of biliary epithelial layer on the tissue-engineered artificial biliary wall, the promotion of new biliary tissue formation, and the regulation of the degradation performance and mechanical properties of artificial biliary duct in order to fundamentally solve the problems encountered in the research of artificial biliary substitutes and accelerate the development of artificial biliary duct.


Assuntos
Ductos Biliares , Engenharia Tecidual , China , Constrição Patológica , Humanos
3.
Int J Med Sci ; 17(12): 1704-1712, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32714073

RESUMO

Background: Gallbladder cancer (GBC) is the most common malignancy of the biliary system. Early T stage GBC patients with distant metastasis are proven to have a worse prognosis. In this study, our aim was to construct and validate a novel nomogram for predicting distant metastasis in T1 and T2 GBC. Methods: Between 2004 and 2014, patients with T1 and T2 GBC were identified in the Surveillance, Epidemiology, and End Results (SEER) database. All of the eligible patients were randomly divided into training and validation cohorts. Univariate and multivariate analyses were used to assess significant predictive factors associated with distant metastasis. A nomogram was developed and validated by a calibration curve and receptor operating characteristic curve (ROC) analysis. Results: According to the inclusion and exclusion criteria, 3013 patients with historically confirmed AJCC stage T1 and T2 GBC were enrolled. Younger age, high pathological grade, nonadenocarcinoma, T1, N1 and larger tumor size correlated positively with the risk of distant metastasis. A novel nomogram was established to predict distant metastasis in early T stage GBC patients. Internal validation with a calibration plot in the training cohort showed that this nomogram was well calibrated. Through ROC curve analysis, the areas under the ROC curves in the training and validation cohorts were 0.723 and 0.679, respectively. Conclusions: Although some limitations exist in this predictive model, the nomogram revealed the relationship between the clinicopathological characteristics of T1 and T2 GBC patients and the risk of distant metastasis. The novel nomogram will assist in patient counseling and guide treatment decision making for T1 and T2 GBC patients.


Assuntos
Carcinoma in Situ/diagnóstico , Neoplasias da Vesícula Biliar/diagnóstico , Metástase Neoplásica/diagnóstico , Nomogramas , Idoso , Carcinoma in Situ/diagnóstico por imagem , Carcinoma in Situ/patologia , Feminino , Neoplasias da Vesícula Biliar/diagnóstico por imagem , Neoplasias da Vesícula Biliar/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Metástase Neoplásica/diagnóstico por imagem , Metástase Neoplásica/patologia , Estadiamento de Neoplasias , Curva ROC , Medição de Risco , Fatores de Risco , Programa de SEER
4.
Biochem Biophys Res Commun ; 515(2): 289-295, 2019 07 23.
Artigo em Inglês | MEDLINE | ID: mdl-31146920

RESUMO

Successful seed germination depends on the rapid repair of cell membrane damaged by dry storage. However, little is known about the reorganization of lipids during this process. In this study, the changes of intracellular redox environment, cell membrane integrity, lipid composition, and expression of genes related to phospholipid metabolism were assessed during imbibition of Brassica napus seeds. A total number of 443 lipids belonging to 7 categories were detected by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS/MS). In the 24 h-imbibed seeds, the relative content of triacylglycerol was lower than in dry seeds, while the relative content of phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS), especially PC (36:2, number of carbons in the acyl chains: number of double bonds), PC (36:3), and PE (36:3) were higher than those in dry seeds. Meanwhile, the content and unsaturation levels of phospholipids increased, indicating membrane lipids remodeling during seed imbibition. The plasma membrane integrity, which was measured by the relative electrolyte leakage (REL) of the membrane and FM4-64 fluorescent dye, was improved upon imbibition, confirming that cell membrane was repaired after 24 h-imbibition. The reduction of H2O2 content, redox potential, and malondialdehyde (MDA) content indicated that the degree of membrane lipid peroxidation was significantly decreased upon imbibition. Gene expression analysis showed that the differential expression of genes for key enzymes occurred in the plateau phase of the imbibition curve, i.e. after 8 h-to 24 h-imbibition. Moreover, the differential expression of genes such as those encoding phospholipase C (PLC), phospholipase D (PLD), triacylglycerol lipase (TAG lipase), choline/ethanolamine phosphotransferase (CEPT), and phosphatidylserine synthase (PTDSS2) during imbibition indicated that membrane lipid remodeling was related to complex metabolic pathways, among which the degradation of triacylglycerol and the synthesis of phospholipids using diacylglycerol might play an important role during membrane remodeling.


Assuntos
Brassica napus/metabolismo , Lipídeos de Membrana/metabolismo , Fosfolipídeos/metabolismo , Brassica napus/genética , Brassica napus/crescimento & desenvolvimento , Membrana Celular/metabolismo , Corantes Fluorescentes , Genes de Plantas , Germinação/genética , Germinação/fisiologia , Lipídeos de Membrana/química , Fosfolipídeos/química , Compostos de Piridínio , Compostos de Amônio Quaternário , Sementes/genética , Sementes/crescimento & desenvolvimento , Sementes/metabolismo , Transcriptoma
5.
J Surg Oncol ; 114(2): 202-10, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27199001

RESUMO

INTRODUCTION: Lymphocytes are an integral part of lymphocyte to monocyte ratio (LMR) and prognostic nutritional index (PNI). Both LMR and PNI which reflect body's inflammatory and nutritional status can be obtained from routine blood and biochemical test conveniently. Little evidence concerning the prognostic value of LMR and PNI in hepatocellular carcinoma (HCC) patients has been published. This study aimed to investigate the prognostic value of LMR and PNI in hepatitis B virals (HBV)-associated HCC patients who underwent curative hepatectomy. METHODS: Between January 2008 and June 2013, 450 surgically treated HCC patients were retrospectively analyzed. Clinicopathological parameters, LMR and PNI were collected and compared. The multivariate analysis was performed to indentify independent prognostic factors. Overall survival (OS) and recurrence-free survival (RFS) rates were also compared. RESULTS: Tumor size, vascular invasion, alpha fetoprotein level, LMR and PNI were independent prognostic factors for OS. Tumor number, tumor size, vascular invasion, LMR and PNI were independent prognostic factors for RFS. Either a high LMR or PNI could predict favorable OS and RFS in surgically treated HCC patients and vice versa. CONCLUSIONS: Both LMR and PNI were significant independent predictors that can predict survival outcomes in HBV-associated HCC patients who received curative hepatectomy. J. Surg. Oncol. 2016;114:202-210. © 2016 Wiley Periodicals, Inc.


Assuntos
Carcinoma Hepatocelular/cirurgia , Hepatectomia/mortalidade , Hepatite B/complicações , Neoplasias Hepáticas/cirurgia , Linfócitos , Monócitos , Avaliação Nutricional , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Hepatocelular/etiologia , Carcinoma Hepatocelular/mortalidade , Feminino , Seguimentos , Previsões , Humanos , Contagem de Leucócitos , Neoplasias Hepáticas/etiologia , Neoplasias Hepáticas/mortalidade , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Prognóstico , Estudos Retrospectivos , Adulto Jovem
6.
Ann Surg Oncol ; 22 Suppl 3: S1048-56, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26286198

RESUMO

BACKGROUND: Hepatocellular carcinoma (HCC) with sarcomatous change (SC) is a rare malignancy associated with high aggressiveness and poor prognosis; however, its prognostic significance remains unclear. METHODS: From January 1994 to April 2012, surgically resected HCCs with SC (n = 52) at West China Hospital were retrospectively reviewed. HCC with SC was defined as the concomitant presence of the sarcomatous component occupying at least 10 % (but not predominantly) of the HCC-bearing tissue. To validate its prognostic significance, we compared the clinicopathological features and survival rates of these patients with a cohort of 214 randomly selected ordinary HCC patients during the same period. RESULTS: The clinicopathological characteristics of HCC with SC were similar to those of ordinary HCC, with the exception of capsule formation, adjacent organ invasion, lymph node metastasis, and TNM staging. A total of 45 (86.5 %) HCC patients with SC experienced a recurrence, with a median time to recurrence of 6.0 months. Overall survival (OS) rates in the sarcomatous HCC group at 1, 2, and 3 years were 55.8, 25, and 17.3 %, respectively, which were significantly lower than those in the ordinary HCC group (p < 0.001). On multivariable analysis, macrovascular invasion, satellite nodules, and R1/R2 resection were identified as independent risk factors for shorter disease-free survival and OS. CONCLUSIONS: The presence of SC in HCC was uncommon, and was associated with much poorer prognosis than ordinary HCC. Radical resection with negative margin is essential for improving the prognosis. Future prospective studies are warranted to determine if recurrent patients can benefit from postoperative adjuvant therapies.


Assuntos
Carcinoma Hepatocelular/cirurgia , Hepatectomia/efeitos adversos , Neoplasias Hepáticas/cirurgia , Complicações Pós-Operatórias , Sarcoma/patologia , Adulto , Idoso , Carcinoma Hepatocelular/secundário , Feminino , Seguimentos , Humanos , Neoplasias Hepáticas/patologia , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Prognóstico , Estudos Retrospectivos , Taxa de Sobrevida , Adulto Jovem
7.
HPB (Oxford) ; 17(3): 195-201, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25209740

RESUMO

OBJECTIVE: The aim of this study was to compare the effectiveness of percutaneous needle aspiration (PNA) and percutaneous catheter drainage (PCD) in the management of liver abscess. METHODS: Electronic searches (Cochrane Library, MEDLINE, EMBASE, SCIE) were conducted to identify randomized controlled trials (RCTs) comparing PNA and PCD. A meta-analysis was subsequently performed. RESULTS: A total of five RCTs covering 306 patients were included. The meta-analysis showed that outcomes in patients treated with PCD were superior to those in patients treated with PNA in terms of success rate [relative risk (RR): 0.81, 95% confidence interval (CI) 0.66-0.99; P = 0.04], clinical improvement [standardized mean difference (SMD): -0.73, 95% CI 0.36-1.11; P = 0.0001] and days to achieve a 50% reduction in abscess cavity size (SMD: -1.08, 95% CI 0.64-1.53; P < 0.00001). No significant differences were found in duration of hospitalization (mean difference: -0.17, 95% CI -2.10 to 1.75; P = 0.86) or procedure-related complications (RR: 0.50, 95% CI 0.10-2.63; P = 0.41). Days to achieve the total or near total resolution of the abscess cavity and mortality were not calculated because data in the RCTs in the meta-analysis were insufficient. CONCLUSIONS: Both PNA and PCD are safe methods of draining liver abscesses. However, PCD is more effective than PNA because it facilitates a higher success rate, reduces the time required to achieve clinical relief and supports a 50% reduction in abscess cavity size. However, among successfully treated patients, the outcomes of PNA are comparable with those of PCD.


Assuntos
Cateterismo/métodos , Drenagem/métodos , Abscesso Hepático/terapia , Sucção/métodos , Drenagem/instrumentação , Feminino , Humanos , Abscesso Hepático/diagnóstico por imagem , Abscesso Hepático/mortalidade , Masculino , Ensaios Clínicos Controlados Aleatórios como Assunto , Medição de Risco , Taxa de Sobrevida , Resultado do Tratamento , Ultrassonografia de Intervenção
8.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 45(4): 628-32, 2014 Jul.
Artigo em Zh | MEDLINE | ID: mdl-25286689

RESUMO

OBJECTIVE: To explore the risk factors of hepatolithasis-associated intrahepatic cholangiocarcinoma (HICC) and the clinical value of serum tumor-related markers for the detection of HICC. METHODS: Clinical data were collected from 58 patients pathologically diagnosed as HICC between 2005 and 2011 in West China Hospital of Sichuan University and 189 patients diagnosed as hepatolithiasis alone in the same period as matched control group. Logistic regression analysis was used to detect the independent risk factors of HICC and ROCs curve were constructed to assess the diagnostic value of CA199, CEA, GGT and ALP. RESULTS: The patients in both HICC group and control group presented similar clinical symptoms except weight loss. The results of univariate analysis suggested cholangioenterostomy (P < 0.001), early stone removal (OR = 0.001), family history of cancer (P = 0.001) were associated with the incidence of HICC. The results of Multivariate analysis suggested diabetes mellitus (OR = 3.621, 95% CI: 1.333-9.834, P = 0.012), family history of cancer (OR = 16.830, 95% CI: 1.937-146.21, P = 0.010), cholangioenterostomy (OR = 5.115, 95% CI: 1.733-15.098, P = 0.003), early removal of stone (OR = 0.315, 95% CI: 0.128-0.771, P = 0.011) and CA199 > 100 IU/mL (OR = 5.478, 95% CI: 2.539-11.820, P < 0.001) were independent risk factors for hICC. Serum CA199 and CEA level presented low diagnostic accuracy, a combined test (CA199 > 100 IU/mL or CEA > 5 ng/mL) showed better diagnostic performance with a 71.05% of sensitivity and 82.05% of specificity. CONCLUSION: Cholangioenterostomy, diabetes, early and complete stone removal were independent risk factors for hepatolithiasis-associated ICC. A combined test of CA199 and CEA could be an effective detecting tool for HICC.


Assuntos
Neoplasias dos Ductos Biliares/diagnóstico , Biomarcadores Tumorais/sangue , Colangiocarcinoma/diagnóstico , Neoplasias dos Ductos Biliares/sangue , Ductos Biliares Intra-Hepáticos , China , Colangiocarcinoma/sangue , Humanos , Fatores de Risco , Sensibilidade e Especificidade
9.
Front Oncol ; 13: 1146933, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37197425

RESUMO

Background: Lymphoepithelioma-like intrahepatic cholangiocarcinoma (LEL-ICC) is a rare variant of intrahepatic cholangiocarcinoma. Epstein-Barr virus (EBV) infection was considered to play a pivotal role in the tumorigenesis of LEL-ICC. It is difficult to diagnosis of LEL-ICC due to the lack of specific features regarding the laboratory test results and imaging findings. At present, the diagnosis of LEL-ICC mainly depends on the histopathologic and immunohistochemical examinations. In addition, the prognosis of LEL-ICC was better than classical cholangiocarcinomas. To our knowledge, only few cases of LEL-ICC have been reported in the literature. Case presentation: We presented a case of a 32-year-old Chinese female with LEL-ICC. She had a 6-month history of upper abdominal pain. The magnetic resonance imaging (MRI) showed a 1.1× 1.3 cm lesion in the left lobe of liver, appearing low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. The patient underwent laparoscopic left lateral sectionectomy. The postoperative histopathologic and immunohistochemical examinations results allowed for the definitive diagnosis of LEL-ICC. The patient was free from tumor recurrence after a 28 months follow-up. Conclusion: In this study, we reported a rare case of LEL-ICC associated with both HBV and EBV infection. EBV infection might play a pivotal role in the carcinogenesis of LEL-ICC, and surgical resection is still the most effective treatment at present. Further research on the etiology and treatment strategies of LEL-ICC is required.

10.
Hepatogastroenterology ; 59(118): 1727-34, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22193435

RESUMO

BACKGROUND/AIMS: To compare the safety and effectiveness of laparoscopic cholecystectomy (LC) versus open cholecystectomy (OC) for cirrhotic patients. METHODOLOGY: The Cochrane Library, MEDLINE, Science Citation Index Expanded, EMBASE and CBM (Chinese Biomedical Database) were searched until August 2011 to indentify relevant and eligible studies. RESULTS: Twenty three articles with 1316 cirrhotic patients were included. All patients were allocated to the LC group (n=694) or the OC group (n=622). They were primarily in Child-Pugh class A (n=957, 72.7%) and class B (n=343, 26.1%). Meta-analysis of 5 randomized controlled trials (n=284) indicated LC group was associated with the following advantages: significant lower surgery-related morbidity, less postoperative complications (e.g. incision hernia, wound infection), shorter hospital stay and less loss of blood. There were no significant differences in the intra-hospital mortality and total operative time between the two groups. Meta-analysis of 19 non-randomized studies (n=1082) showed similar results in favour of LC group. In addition, it showed significant lower intra-hospital mortality and less total operative time in the LC group than the OC group. CONCLUSIONS: LC is safe and offers various significant benefits over OC. Thus, it should be recommended for compensated cirrhotic patients.


Assuntos
Colecistectomia Laparoscópica , Colecistectomia/métodos , Cirrose Hepática/cirurgia , Distribuição de Qui-Quadrado , Colecistectomia/efeitos adversos , Colecistectomia/mortalidade , Colecistectomia Laparoscópica/efeitos adversos , Colecistectomia Laparoscópica/mortalidade , Mortalidade Hospitalar , Humanos , Tempo de Internação , Cirrose Hepática/diagnóstico , Cirrose Hepática/mortalidade , Razão de Chances , Seleção de Pacientes , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/mortalidade , Medição de Risco , Fatores de Risco , Índice de Gravidade de Doença , Fatores de Tempo , Resultado do Tratamento
11.
Hepatogastroenterology ; 59(119): 2064-74, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22282127

RESUMO

BACKGROUND/AIMS: The incidence of postoperative nausea and vomiting is truly high after laparoscopic cholecystectomy. Ondansetron and metoclopramide may be effective in preventing it. Our aim was to estimate the efficacy of ondansetron vs. metoclopramide in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy. METHODOLOGY: We searched MEDLINE (PubMed), Cochrane Central Register of Controlled Trials (CENTRAL), Science Citation Index Expanded, EMBASE etc. to obtain relevant randomized controlled trials until October 2011. Two authors independently assessed the trials for inclusion and extracted the data. The odds ratio (OR) for dichotomous data was used with 95% confidence intervals (CI). Sensitivity and subgroup analysis were performed, if necessary. RESULTS: The total incidence of postoperative nausea and vomiting within 24 hours after laparoscopic cholecystectomy was 31% (74 of 235) in the ondansetron group and 56% (127 of 225) in the metoclopramide group (OR=0.33, 95%CI=0.22-0.49, p<0.00001, 12=49%). The total incidences of nausea and vomiting were lower in the ondansetron group (OR=0.28, 95%CI=0.15-0.54, p=0.0002, I²=0%) and (OR=0.31, 95%CI=0.17-0.55, p<0.0001, I²=0%), respectively. CONCLUSIONS: Based on the evidence, ondansetron has a better effect than metoclopramide for preventing postoperative nausea and vomiting after laparoscopic cholecystectomy. If we ignore the price factor, ondansetron is recommended for adhibition.


Assuntos
Antieméticos/administração & dosagem , Colecistectomia Laparoscópica/efeitos adversos , Metoclopramida/administração & dosagem , Ondansetron/administração & dosagem , Náusea e Vômito Pós-Operatórios/prevenção & controle , Esquema de Medicação , Feminino , Humanos , Incidência , Masculino , Razão de Chances , Náusea e Vômito Pós-Operatórios/epidemiologia , Fatores de Tempo , Resultado do Tratamento
12.
Hepatogastroenterology ; 59(116): 1220-4, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22366389

RESUMO

BACKGROUND/AIMS: Research on the influence of pre-operation usage of steroids for liver cirrhosis patients performed major liver resection (=3 segments). METHODOLOGY: In total, 741 cirrhosis patients who underwent major hepatectomy (>3 segments) in our medical center were selected for the study. One hundred and five out of 741 patients used 500 mg methylprednisolone between half an hour and one hour before operation and were enrolled in the steroids group. The other 636 patients without steroid injection were assigned in the control group. Our analysis compared the data of bilirubin, ALT, AST, postoperative PT, complications, mortality, IL-6, average length of hospitalization and the like. RESULTS: Blood sample test showed level of bilirubin and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and prothrombin time (PT), IL-6 were significantly lower in the steroids group than the control group in the postoperative days. There were no differences of mortality, morbidity and length of stay between the two groups. CONCLUSIONS: Methylprednisolone used in preoperative period could degrade the bilirubin and IL-6 level safely and effectively after operation but does not reduce the mortality and the average hospital stay for liver sclerotic patients with normal liver function with slight side effects; it may have positive clinical effects for marginal liver patients.


Assuntos
Hepatectomia , Cirrose Hepática/tratamento farmacológico , Metilprednisolona/uso terapêutico , Adolescente , Adulto , Idoso , Bilirrubina/sangue , Feminino , Hepatectomia/efeitos adversos , Humanos , Interleucina-6/sangue , Cirrose Hepática/sangue , Cirrose Hepática/etiologia , Masculino , Pessoa de Meia-Idade , Período Pré-Operatório , Estudos Retrospectivos
13.
Front Plant Sci ; 13: 908949, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35812982

RESUMO

Seed viability depends upon the maintenance of functional lipids; however, how membrane lipid components dynamically change during the seed aging process remains obscure. Seed storage is accompanied by the oxidation of membrane lipids and loss of seed viability. Understanding membrane lipid changes and their effect on the cell membrane during seed aging can contribute to revealing the mechanism of seed longevity. In this study, the potential relationship between oxidative stress and membrane lipid metabolism was evaluated by using a non-targeted lipidomics approach during artificial aging of Glycine max L. Merr. Zhongdou No. 27 seeds. We determined changes in reactive oxygen species, malondialdehyde content, and membrane permeability and assessed antioxidant system activity. We found that decreased non-enzymatic antioxidant contents and catalase activity might lead to reactive oxygen species accumulation, resulting in higher electrolyte leakage and lipid peroxidation. The significantly decreased phospholipids and increased glycerolipids and lysophospholipids suggested that hydrolysis of phospholipids to form glycerolipids and lysophospholipids could be the primary pathway of membrane metabolism during seed aging. Moreover, the ratio of phosphatidylcholine to phosphatidylethanolamine, double bond index, and acyl chain length of phospholipids were found to jointly regulate membrane function. In addition, the observed changes in lipid metabolism suggest novel potential hallmarks of soybean seed aging, such as diacylglycerol 36:4; phosphatidylcholine 34:2, 36:2, and 36:4; and phosphatidylethanolamine 34:2. This knowledge can be of great significance for elucidating the molecular mechanism underlying seed aging and germplasm conservation.

14.
Hepatobiliary Pancreat Dis Int ; 10(6): 570-80, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22146619

RESUMO

BACKGROUND: Reports on the relationship between pancreaticobiliary maljunction (PBM) and gallbladder carcinoma (GBC) are conflicting. The frequency of PBM in GBC patients and the clinical features of GBC patients with PBM vary in different studies. DATA SOURCES: English-language articles describing the association between PBM and GBC were searched in the PubMed and Web of Science databases. Nine case-control studies fulfilled the inclusion criteria and addressed the relevant clinical questions of this analysis. Data were extracted independently by two reviewers using a predefined spreadsheet. RESULTS: The incidence of PBM was higher in GBC patients than in controls (10.60% vs 1.76%, OR: 7.41, 95% CI: 5.03 to 10.87, P<0.00001). The proportion of female patients with PBM was 1.96-fold higher than in GBC patients without PBM (80.5% vs 62.9%, OR: 1.96, 95% CI: 1.09 to 3.52, P=0.12). GBC patients with PBM were 10 years younger than those without PBM (SMD: -9.90, 95% CI: -11.70 to -8.10, P<0.00001). And a difference in the incidence of associated gallstone was found between GBC patients with and without PBM (10.8% vs 54.3%, OR: 0.09, 95% CI: 0.05 to 0.17, P<0.00001). Among the GBC patients with PBM, associated congenital dilatation of the common bile duct was present with a higher incidence ranging from 52.2% to 85.7%, and 70.0%-85.7% of them belonged to the P-C type of PBM (the main pancreatic duct enters the common bile duct). No substantial heterogeneity was found and no evidence of publication bias was observed. CONCLUSIONS: PBM is a high-risk factor for developing GBC, especially the P-C type of PBM without congenital dilatation of the common bile duct. To prevent GBC, laparoscopic cholecystectomy is highly recommended for PBM patients without congenital dilatation of the common bile duct, especially relatively young female patients without gallstones.


Assuntos
Anormalidades Múltiplas , Doenças do Ducto Colédoco/complicações , Ducto Colédoco/anormalidades , Neoplasias da Vesícula Biliar/etiologia , Pancreatopatias/complicações , Ductos Pancreáticos/anormalidades , Colangiopancreatografia Retrógrada Endoscópica , Doenças do Ducto Colédoco/congênito , Doenças do Ducto Colédoco/diagnóstico , Dilatação Patológica/congênito , Dilatação Patológica/diagnóstico , Neoplasias da Vesícula Biliar/diagnóstico , Humanos , Pancreatopatias/congênito , Pancreatopatias/diagnóstico
15.
Am J Surg ; 221(3): 642-648, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-32859350

RESUMO

BACKGROUND: The effect of postsurgical radiotherapy (PSRT) among T1-3 gallbladder cancer (GBC) patients with one to three lymph node metastases remains controversial. The aim of this study was to assess the impact of PSRT on gallbladder cancer-specific survival (GBCSS) in patients with stage IIIB. METHODS: The data of GBC patients were obtained from the American Surveillance, Epidemiology, and End Results (SEER) Data resources between 2004 and 2015. Then, a 1:1 propensity score matching (PSM) method was performed. GBCSS was compared among all patients. Subgroup analysis was conducted to identify patients who would benefit from PSRT. RESULTS: 726 AJCC (8th edition) stage IIIB GBC patients were included. PSRT failed to improve GBCSS (p = 0.168). Male sex, tumor size ≥ 4 cm and absence of chemotherapy were independent negative prognostic factors. No significant survival benefit from PSRT was found in any subgroup. CONCLUSIONS: PSRT provides no survival benefit for IIIB GBC.


Assuntos
Adenocarcinoma/radioterapia , Adenocarcinoma/cirurgia , Colecistectomia , Neoplasias da Vesícula Biliar/radioterapia , Neoplasias da Vesícula Biliar/cirurgia , Adenocarcinoma/patologia , Adulto , Idoso , Feminino , Neoplasias da Vesícula Biliar/patologia , Humanos , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Pontuação de Propensão , Radioterapia Adjuvante , Programa de SEER , Taxa de Sobrevida , Resultado do Tratamento , Estados Unidos
16.
Hepatobiliary Pancreat Dis Int ; 8(3): 241-6, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19502162

RESUMO

BACKGROUND: Human CD8+CD28- T-suppressor (Ts) cells have been considered to indicate a reduced need for immunosuppression in pediatric liver-intestine transplant recipients and recipients of deceased heart-kidney transplants. However, in adult-to-adult living donor liver transplantation (A-A LDLT) little information is available and the clinical significance is still unknown. METHODS: Flow cytometry was used to detect the population of CD8+CD28- Ts cells present in peripheral blood in A-A LDLT recipients (n=31), patients with end-stage liver disease (n=24) and healthy controls (n=19). Meanwhile, we tested the graft function and trough levels of immunosuppression in recipients. The clinical and follow-up data of 31 transplant recipients were analyzed. RESULTS: Compared with diseased controls (P=0.007) and healthy individuals (P=0.000), a notable expansion of CD8+CD28- Ts cells was found in recipients of A-A LDLT. This was associated with graft function, levels of immunosuppression and rejection episodes. CONCLUSIONS: To monitor the CD8+CD28- Ts cells levels is important to evaluate the immune state of recipients. Meanwhile, it is also important to promote expansion of CD8+CD28- Ts cells in recipients of A-A LDLT, not only to sustain good graft function and decrease the dosage of immunosuppressants, but also to reduce the occurrence of rejection.


Assuntos
Antígenos CD28/análise , Linfócitos T CD8-Positivos/imunologia , Transplante de Fígado/imunologia , Doadores Vivos , Adulto , Feminino , Citometria de Fluxo , Seguimentos , Rejeição de Enxerto , Humanos , Terapia de Imunossupressão , Hepatopatias/complicações , Falência Hepática/etiologia , Falência Hepática/cirurgia , Neoplasias Hepáticas/classificação , Transplante de Fígado/mortalidade , Masculino , Pessoa de Meia-Idade , Adulto Jovem
18.
Artigo em Zh | MEDLINE | ID: mdl-31245955

RESUMO

OBJECTIVE: To observe the effects of Shenmai injection(SM) on p38MAPK and the apoptosis-related genes in lung injury induced by intestinal ischemia reperfusion (I/R) in rats and to investigate the protective mechanism of SM. METHODS: Rat model of intestinal I/R injury was established with clamping of the superior mesenteric artery (SMA) for 60 min and then clamping was relieved for 60 min. Twenty-four SD rats were randomly divided into three groups with eight rats in each: control group, intestinal ischemia/reperfusion group(I/R group), Shenmai injection treated group (SM+I/R group). Lung wet/dry weight ratio(W/D), the contents of phosphatidylcholine (PC) and total phospholipid(TPL) which are the major ingredients of pulmonary surfactant were measured, as well as the expression levels of p38MAPK, Bcl-2 and Bax proteins in lung tissue were examined by using immunohistochemical method. RESULTS: Compared with control group, lung W/D was significantly increased, the contents of PC and TPL were significantly decreased, the protein expression levels of p38MAPK, Bcl-2 and Bax were significantly increased in I/R group (all P<0.01). But Bax protein expression was much greater than Bcl-2 protein expression, the ratio of Bcl-2 to Bax were significantly decreased in I/R group than that in control group (P<0.01). Compared with I/R group, lung W/D was significantly decreased, while the contents of PC and TPL were significantly increased, the p38MAPK and Bax protein expression levels were significantly decreased in SM+I/R group (all P<0.01); both Bcl-2 protein expression and the ratio of Bcl-2 to Bax were significantly increased in SM+I/R group than those in I/R group (P<0.01). The correlation analysis indicated that the expression level of p38MAPK protein in lung tissue was negatively correlated with the contents of PC and the ratio of Bcl-2 to Bax (r is -0.787 and -0.731, all P<0.01). CONCLUSION: SM can protect the lung injury induced by intestinal I/R injury, which may be mediated by inhibiting the activation of p38MAPK, improving the ratio of Bcl-2 to Bax to inhibit lung apoptosis.


Assuntos
Medicamentos de Ervas Chinesas , Lesão Pulmonar , Traumatismo por Reperfusão , Proteínas Quinases p38 Ativadas por Mitógeno , Animais , Apoptose , Combinação de Medicamentos , Medicamentos de Ervas Chinesas/farmacologia , Lesão Pulmonar/tratamento farmacológico , Lesão Pulmonar/genética , Proteínas Proto-Oncogênicas c-bcl-2 , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Traumatismo por Reperfusão/complicações , Proteína X Associada a bcl-2 , Proteínas Quinases p38 Ativadas por Mitógeno/efeitos dos fármacos , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA